(Q43859356)

27 November 2017

0 references

1 reference

title

Radical prostatectomy and early adjuvant hormonal therapy for pTxN+ adenocarcinoma of the prostate (English)

1 reference

27 November 2017

Seay TM

1

1 reference

27 November 2017

Blute MC

series ordinal

2

1 reference

27 November 2017

Zincke H

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

27 November 2017

1 reference

27 November 2017

volume

50

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

833-837

1 reference

27 November 2017

cites work

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

The Impact of Current Staging Procedures in Assessing Disease Extent of Prostatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Prostatic Carcinoma: Incidence and Location of Unsuspected Lymphatic Metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Relationship between grade and stage of adenocarcinoma of the prostate and regional pelvic lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Staging pelvic lymphadenectomy for carcinoma of the prostate review of 91 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Evaluation of the current incidence of nodal metastasis from prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

One hundred thirteen men with hormone-refractory prostate cancer died today

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

The Value of Testosterone Deprivation in Stage D1 Carcinoma of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Extended field radiation therapy versus delayed hormonal therapy in node positive prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Prognosis of Patients With Stage D1 Prostatic Adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Impact of external irradiation on local symptoms and survival free of disease in patients with pelvic lymph node metastasis from adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Combined hormonal and radiation therapy for lymph node-positive prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Management of Stage D1 Adenocarcinoma of the Prostate: The Johns Hopkins Experience 1974 to 1987

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Prognosis of patients with stage D1 prostate carcinoma following radical prostatectomy with and without early endocrine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Survival and quality of life of patients with stage D1 (T1-3 pN1-2 M0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900482-2

7 January 2021

10.1016/S0090-4295(97)00482-2

Identifiers

DOI

1 reference

27 November 2017

1 reference